New test aims to spot deadly blood clots in cancer patients before they strike
NCT ID NCT06051214
Summary
This study is testing whether a new blood test can predict which cancer patients are most likely to develop dangerous blood clots. Researchers will track 200 patients with lung, pancreatic, stomach, or brain cancer for one year after they start treatment, taking monthly blood samples. The goal is to see if changes in the blood test results can warn doctors about clot risk before it happens.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Cancerologie de L'Ouest
RECRUITINGSaint-Herblain, 44805, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.